Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
Lung Cancer
University of Chicagomonoclonal_antibodyPhase 2/3Active
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 57/ 100
- Competitive Position
- 81/ 100
Competitive context
298 Active assets in the Lung Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cis-Diamminedichloroplatinum Ii University of Vermont | Phase 4 | BB |
Carboplatin SystImmune Inc. | Phase 4 | BB |
Desflurane Peter MacCallum Cancer Centre, Australia | Phase 4 | BB |
Etoposide SystImmune Inc. | Phase 3 | BB |
Nivolumab University of Chicago | Phase 4 | BB |
View all 50 →
Same molecule, other indications
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →